|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.890 EUR | +0.10% |
|
-0.61% | +1.24% |
| 06-18 | Nordea raises target price for Lundbeck to DKK60 (57), reiterates buy rating | FW |
| 06-14 | H. Lundbeck A/S Presents Preliminary Phase II Part A Data for Asedebart in Cushing's Disease | CI |
Company Valuation: Lundbeck
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 25,433 | 31,719 | 39,416 | 41,398 | 40,544 | - | - |
| Change | - | 24.72% | 24.27% | 5.03% | -2.06% | - | - |
| Enterprise Value (EV) 1 | 27,464 | 31,008 | 51,598 | 49,619 | 44,632 | 40,500 | 36,779 |
| Change | - | 12.91% | 66.4% | -3.84% | -10.05% | -9.26% | -9.19% |
| P/E | 13.5x | 14.2x | 13x | 13.4x | 9.22x | 9.18x | 9.85x |
| PBR | 1.24x | 1.47x | 1.64x | 1.72x | 1.46x | 1.31x | 1.2x |
| PEG | - | 0.7x | 0.3x | 8.5x | 0.2x | 18.55x | -1.44x |
| Capitalization / Revenue | 1.39x | 1.59x | 1.79x | 1.68x | 1.57x | 1.57x | 1.62x |
| EV / Revenue | 1.51x | 1.56x | 2.34x | 2.01x | 1.73x | 1.57x | 1.47x |
| EV / EBITDA | 5.89x | 5.49x | 8.13x | 6.3x | 5.52x | 5.02x | 4.83x |
| EV / EBIT | 9.63x | 9.71x | 15.8x | 9.41x | 7.37x | 6.6x | 6.42x |
| EV / FCF | 10.2x | 8.66x | 18.7x | 10.2x | 7.88x | 6.56x | 6.72x |
| FCF Yield | 9.83% | 11.5% | 5.35% | 9.8% | 12.7% | 15.2% | 14.9% |
| Dividend per Share 2 | 0.58 | 0.7 | 0.95 | 1.15 | 1.5 | 1.536 | 1.496 |
| Rate of return | 2.23% | 2.14% | 2.3% | 2.66% | 3.56% | 3.65% | 3.55% |
| EPS 2 | 1.93 | 2.31 | 3.17 | 3.22 | 4.566 | 4.589 | 4.274 |
| Distribution rate | 30.1% | 30.3% | 30% | 35.7% | 32.9% | 33.5% | 35% |
| Net sales 1 | 18,246 | 19,912 | 22,004 | 24,630 | 25,803 | 25,869 | 25,093 |
| EBITDA 1 | 4,663 | 5,652 | 6,347 | 7,881 | 8,083 | 8,065 | 7,610 |
| EBIT 1 | 2,852 | 3,195 | 3,270 | 5,275 | 6,052 | 6,135 | 5,726 |
| Net income 1 | 1,916 | 2,290 | 3,143 | 3,192 | 4,553 | 4,597 | 4,270 |
| Net Debt 1 | 2,031 | -711 | 12,182 | 8,221 | 4,088 | -44.13 | -3,765 |
| Reference price 2 | 26.05 | 32.76 | 41.32 | 43.16 | 42.12 | 42.12 | 42.12 |
| Nbr of stocks (in thousands) | 992,840 | 992,840 | 992,011 | 991,227 | 991,227 | - | - |
| Announcement Date | 2/7/23 | 2/7/24 | 2/5/25 | 2/4/26 | - | - | - |
1DKK in Million2DKK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 19.88x | 0.24x | 13.75x | 0.4% | 98.45B | ||
| 29.31x | 0.23x | 14.72x | 0.91% | 53.41B | ||
| 44.51x | 3.14x | 29.2x | 1.39% | 22.84B | ||
| 11.46x | 0.2x | 4.82x | 2.64% | 8.13B | ||
| 12.84x | 0.98x | 7.86x | 2.65% | 7.4B | ||
| 5.92x | 0.1x | 2.65x | 5% | 6.7B | ||
| 25.27x | 1.19x | 14.98x | 2.95% | 5.29B | ||
| 10.72x | 0.12x | 4.44x | 4.17% | 3.69B | ||
| 14.39x | - | - | 2.36% | 3.6B | ||
| Average | 19.37x | 0.78x | 11.55x | 2.5% | 23.28B | |
| Weighted average by Cap. | 23.83x | 0.60x | 14.66x | 1.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HLUN B Stock
- LUNA Stock
- Valuation Lundbeck
Select your edition
All financial news and data tailored to specific country editions
















